UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 36

Sortiert nach

Quality of Life in Patients with Allergic Reactions to Medications: Influence of a Drug Allergy Evaluation

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2019-11, Vol.7 (8), p.2714-2721

2019

Link zum Volltext

Verfügbarkeit prüfen

Characteristics, quality of life and control of respiratory allergic diseases caused by house dust mites (HDMs) in Spain: a cross‐sectional study

Clinical and translational allergy, 2019-08, Vol.9 (1), p.39-n/a, Article 39

2019

Link zum Volltext

Verfügbarkeit prüfen

Distearyl phthalic acid amide, a new contact allergen

Contact dermatitis, 2014-11, Vol.71 (5), p.310-312

2014

Link zum Volltext

Verfügbarkeit prüfen

Monitoring of COVID-19 patients by telemedicine with telemonitoring

Revista clínica espanõla, 2020-11, Vol.220 (8), p.472-479

2020

Link zum Volltext

Verfügbarkeit prüfen

Sialoadenitis por contrastes iodados en pacientes con insuficiencia renal crónica, papel de la hemodialisis

Nefrología, 2024-01

2024

Link zum Volltext

Verfügbarkeit prüfen

Smoking, environmental tobacco smoke, and aspirin-exacerbated respiratory disease

Annals of allergy, asthma, & immunology, 2012, Vol.108 (1), p.14-19

2012

Link zum Volltext

Verfügbarkeit prüfen

Allergic reactions to nonsteroidal anti-inflammatory drugs: is newer better?

Current allergy and asthma reports, 2007-04, Vol.7 (1), p.35-40

2007

Link zum Volltext

Verfügbarkeit prüfen

Allergy to Blue Dye

Journal of investigational allergology & clinical immunology, 2016-01, Vol.26 (6), p.381-383

2016

Link zum Volltext

Verfügbarkeit prüfen

PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis

Journal of clinical medicine, 2020-07, Vol.9 (7), p.2093

2020

Link zum Volltext

Verfügbarkeit prüfen

Real-world data with afatinib in Spanish patients with treatment-naïve non-small-cell lung cancer harboring exon 19 deletions in epidermal growth factor receptor (Del19 EGFR): Clinical experience of the Galician Lung Cancer Group

Cancer treatment and research communications, 2022, Vol.33, p.100646, Article 100646

2022

Link zum Volltext

Verfügbarkeit prüfen

Analysis of the relationship between ratio N/L and survival in lung cancer patients treated with immunotherapy

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e14247-e14247

2019

Link zum Volltext

Verfügbarkeit prüfen

Cost analysis of the management of brain metastases in patients with advanced ALK+ NSCLC: alectinib versus crizotinib

Lung cancer management, 2020-03, Vol.9 (1)

2020

Link zum Volltext

Verfügbarkeit prüfen

First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients

Expert opinion on pharmacotherapy, 2012-07, Vol.13 (10), p.1389-1396

2012

Link zum Volltext

Verfügbarkeit prüfen

Full-dose cisplatin and oral vinorelbine concomitant with radiotherapy in unresectable stage III non-small cell lung cancer: a multi-center phase II study

Anticancer research, 2014-04, Vol.34 (4), p.1959-1966

2014

Link zum Volltext

Verfügbarkeit prüfen

Second-line treatment in advanced non-small-cell lung cancer in the epidermal growth factor receptor wild-type population: review of patient profile

Anti-cancer drugs, 2014-04, Vol.25 (4), p.368-374

2014

Link zum Volltext

Verfügbarkeit prüfen

EGFR testing and clinical management of advanced NSCLC: a Galician Lung Cancer Group study (GGCP 048-10)

Cancer management and research, 2016-01, Vol.8 (Issue 1), p.11-20

2016

Link zum Volltext

Verfügbarkeit prüfen

P2-317: Biweekly paclitaxel as second-line treatment in advanced non-small-cell-lung-cancer (NSCLC). A phase II study of the Lung Cancer Galician Group

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S699-S699

2007

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of clinical use and effectiveness of darbepoetin alfa in cancer patients with chemotherapy-induced anemia

Current medical research and opinion, 2012-01, Vol.28 (1), p.57-67

2012

Link zum Volltext

Verfügbarkeit prüfen

The Cantabria Cohort, a protocol for a population-based cohort in northern Spain

BMC public health, 2023-12, Vol.23 (1), p.2429-2429, Article 2429

2023

Link zum Volltext

Verfügbarkeit prüfen

Biweekly administration of docetaxel and vinorelbine as second-line chemotherapy for patients with stage IIIB and IV non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 013-02)

Anti-cancer drugs, 2007-11, Vol.18 (10), p.1201-1206

2007

Link zum Volltext

Verfügbarkeit prüfen

The real-world experience with nivolumab in previously treated patients with advanced non small cell lung cancer (NSCLC): A Galician Lung Cancer Group clinical practice

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e20564-e20564

2017

Link zum Volltext

Verfügbarkeit prüfen

An observational study of the efficacy and safety of nivolumab in pretreated patients with advanced non small cell lung cancer (NSCLC): A Galician Lung Cancer Group Clinical Practice

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e20612-e20612

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(36)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(12)
Oncology
(10)
Aged
(8)
Female
(8)
Middle Aged
(8)
Lung Cancer
(7)
Male
(7)
Adult
(6)
Allergy
(6)
Aged, 80 And Over
(4)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(4)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(4)
Chemotherapy
(4)
Immunology
(4)
Lung Neoplasms - Drug Therapy
(4)
Mutation
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Biopsy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quality of Life in Patients with Allergic Reactions to Medications: Influence of a Drug Allergy Evaluation

Characteristics, quality of life and control of respiratory allergic diseases caused by house dust mites (HDMs) in Spain: a cross‐sectional study

Distearyl phthalic acid amide, a new contact allergen

Monitoring of COVID-19 patients by telemedicine with telemonitoring

Sialoadenitis por contrastes iodados en pacientes con insuficiencia renal crónica, papel de la hemodialisis

Smoking, environmental tobacco smoke, and aspirin-exacerbated respiratory disease

Allergic reactions to nonsteroidal anti-inflammatory drugs: is newer better?

Allergy to Blue Dye

PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis

Real-world data with afatinib in Spanish patients with treatment-naïve non-small-cell lung cancer harboring exon 19 deletions in epidermal growth factor receptor (Del19 EGFR): Clinical experience of the Galician Lung Cancer Group

Real world data of nivolumab for previously treated non-small cell lung cancer patients: a Galician lung cancer group clinical experience

Fluorescence in situ hybridization analysis of the ALK gene in 2,045 non-small cell lung cancer patients from North-Western Spain (Galicia)

Analysis of the relationship between ratio N/L and survival in lung cancer patients treated with immunotherapy

Cost analysis of the management of brain metastases in patients with advanced ALK+ NSCLC: alectinib versus crizotinib

First-line bevacizumab, cisplatin and vinorelbine plus maintenance bevacizumab in advanced non-squamous non-small cell lung cancer chemo-naïve patients

Full-dose cisplatin and oral vinorelbine concomitant with radiotherapy in unresectable stage III non-small cell lung cancer: a multi-center phase II study

Second-line treatment in advanced non-small-cell lung cancer in the epidermal growth factor receptor wild-type population: review of patient profile

EGFR testing and clinical management of advanced NSCLC: a Galician Lung Cancer Group study (GGCP 048-10)

P2-317: Biweekly paclitaxel as second-line treatment in advanced non-small-cell-lung-cancer (NSCLC). A phase II study of the Lung Cancer Galician Group

Evaluation of clinical use and effectiveness of darbepoetin alfa in cancer patients with chemotherapy-induced anemia

Efficacy and safety of Nivolumab in older patients with pretreated lung cancer: A subgroup analysis of the Galician lung cancer group

The Cantabria Cohort, a protocol for a population-based cohort in northern Spain

Biweekly administration of docetaxel and vinorelbine as second-line chemotherapy for patients with stage IIIB and IV non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 013-02)

The real-world experience with nivolumab in previously treated patients with advanced non small cell lung cancer (NSCLC): A Galician Lung Cancer Group clinical practice

An observational study of the efficacy and safety of nivolumab in pretreated patients with advanced non small cell lung cancer (NSCLC): A Galician Lung Cancer Group Clinical Practice

Suchergebnisse filtern